Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Douglas Dynamics (PLOW) Q3 Earnings and Revenues Surpass Estimates
Douglas Dynamics (PLOW) Q3 Earnings and Revenues Surpass Estimates

Douglas Dynamics (PLOW) came out with quarterly earnings of $0.4 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.24 per share a year ago. These

Crescent Energy (CRGY) Q3 Earnings Top Estimates
Crescent Energy (CRGY) Q3 Earnings Top Estimates

Crescent Energy (CRGY) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.39 per share a year ago. These

Myriad (MYGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Myriad (MYGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended September 2025, Myriad Genetics (MYGN) reported revenue of $205.7 million, down 3.6% over the same period last year. EPS came in at $0, compared to $0.06 in the year-ago

Compared to Estimates, National Storage (NSA) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, National Storage (NSA) Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2025, National Storage (NSA) reported revenue of $188.7 million, down 2.5% over the same period last year. EPS came in at $0.57, compared to $0.18 in the year-ago

EverQuote (EVER) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
EverQuote (EVER) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

EverQuote (EVER) reported $173.94 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 20.4%. EPS of $0.50 for the same period compares to $0.31 a year

Goodyear (GT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Goodyear (GT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Goodyear (GT) reported $4.65 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 3.7%. EPS of $0.28 for the same period compares to $0.37 a year ago.

Centerspace (CSR) Q3 FFO Miss Estimates
Centerspace (CSR) Q3 FFO Miss Estimates

Centerspace (CSR) came out with quarterly funds from operations (FFO) of $1.19 per share, missing the Zacks Consensus Estimate of $1.22 per share. This compares to FFO of $1.18 per share a year ago

IAC (IAC) Reports Q3 Earnings: What Key Metrics Have to Say
IAC (IAC) Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended September 2025, IAC (IAC) reported revenue of $589.79 million, down 37.2% over the same period last year. EPS came in at -$0.27, compared to -$2.93 in the year-ago quarter.

The

Ryman Hospitality Properties (RHP) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Ryman Hospitality Properties (RHP) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended September 2025, Ryman Hospitality Properties (RHP) reported revenue of $592.46 million, up 7.7% over the same period last year. EPS came in at $1.63, compared to $0.94 in the

Energy Fuels (UUUU) Reports Q3 Loss, Tops Revenue Estimates
Energy Fuels (UUUU) Reports Q3 Loss, Tops Revenue Estimates

Energy Fuels (UUUU) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.07 per share a year ago. These figures are

UMH Properties (UMH) Meets Q3 FFO Estimates
UMH Properties (UMH) Meets Q3 FFO Estimates

UMH Properties (UMH) came out with quarterly funds from operations (FFO) of $0.25 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.24 per share a year ago. These

Primoris Services (PRIM) Beats Q3 Earnings and Revenue Estimates
Primoris Services (PRIM) Beats Q3 Earnings and Revenue Estimates

Primoris Services (PRIM) came out with quarterly earnings of $1.88 per share, beating the Zacks Consensus Estimate of $1.32 per share. This compares to earnings of $1.22 per share a year ago. These

Gladstone Commercial (GOOD) Q3 FFO Miss Estimates
Gladstone Commercial (GOOD) Q3 FFO Miss Estimates

Gladstone Commercial (GOOD) came out with quarterly funds from operations (FFO) of $0.35 per share, missing the Zacks Consensus Estimate of $0.39 per share. This compares to FFO of $0.38 per share a

JBT Marel (JBTM) Beats Q3 Earnings and Revenue Estimates
JBT Marel (JBTM) Beats Q3 Earnings and Revenue Estimates

JBT Marel (JBTM) came out with quarterly earnings of $1.94 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to earnings of $1.5 per share a year ago. These figures

Innovex International (INVX) Q3 Earnings Lag Estimates
Innovex International (INVX) Q3 Earnings Lag Estimates

Innovex International (INVX) came out with quarterly earnings of $0.18 per share, missing the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.25 per share a year ago

Boise Cascade (BCC) Matches Q3 Earnings Estimates
Boise Cascade (BCC) Matches Q3 Earnings Estimates

Boise Cascade (BCC) came out with quarterly earnings of $0.58 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $2.33 per share a year ago. These figures are

Insperity, Inc. (NSP) Reports Q3 Loss, Lags Revenue Estimates
Insperity, Inc. (NSP) Reports Q3 Loss, Lags Revenue Estimates

Insperity, Inc. (NSP) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of $0.22. This compares to earnings of $0.39 per share a year ago. These figures are

Helios Technologies (HLIO) Tops Q3 Earnings and Revenue Estimates
Helios Technologies (HLIO) Tops Q3 Earnings and Revenue Estimates

Helios Technologies (HLIO) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.59 per share a year ago

HealthStream (HSTM) Q3 Earnings and Revenues Surpass Estimates
HealthStream (HSTM) Q3 Earnings and Revenues Surpass Estimates

HealthStream (HSTM) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.19 per share a year ago. These

Cabot (CBT) Lags Q4 Earnings and Revenue Estimates
Cabot (CBT) Lags Q4 Earnings and Revenue Estimates

Cabot (CBT) came out with quarterly earnings of $1.7 per share, missing the Zacks Consensus Estimate of $1.72 per share. This compares to earnings of $1.8 per share a year ago. These figures are

Inspire (INSP) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Inspire (INSP) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Inspire Medical Systems (INSP) reported $224.5 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 10.5%. EPS of $0.38 for the same period compares to

Compared to Estimates, Vornado (VNO) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, Vornado (VNO) Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2025, Vornado (VNO) reported revenue of $453.7 million, up 2.4% over the same period last year. EPS came in at $0.57, compared to -$0.10 in the year-ago quarter.

The

Compared to Estimates, Corebridge (CRBG) Q3 Earnings: A Look at Key Metrics
Compared to Estimates, Corebridge (CRBG) Q3 Earnings: A Look at Key Metrics

Corebridge Financial (CRBG) reported $5.63 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 24.1%. EPS of $0.96 for the same period compares to

Unitil (UTL) Tops Q3 Earnings Estimates
Unitil (UTL) Tops Q3 Earnings Estimates

Unitil (UTL) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to earnings of $0.02 per share a year ago. These

Halozyme Therapeutics (HALO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Halozyme Therapeutics (HALO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Halozyme Therapeutics (HALO) reported $354.26 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 22.1%. EPS of $1.72 for the same period compares to